Cinnagen
About us | With less than 10 years of experience in manufacturing of molecular biology, biopharmaceuticals and diagnostic products, cinnagen has been able to be well known among national and international end users. Founded in 1992, cinnagen currently manufactures more than 42 products and distribute more than 120 different laboratory diagnostic reagents for in vitro use. Two of our products are lhrh-a and buserelin acetate. Both of them are analogues of gnrh. The first is 30 times more efficience than human gnrh and is for veterinary use only. It is used for the fertility disorders by ovarian disfunction, fixing time of valuation, prophylaxis of fertility disorders by early induction of cycle postpartum and improvement of conception rate. The second is used for the suppression of testosterone in the treatment of malignant neoplasms of the prostate. They are ready for sell. Cinnagen as the only biotech company in the region with research and development goal has gathered high number of expertise with extensive experience in areas of molecular biology, recombinant dna technology and cell biology as the back bone of our new products. In addition, cinnagen has opened a new door for other manufacturers in the region to play as the research consultant in area of biotechnology for development of new products. Our main goal at cinnagen is to be one of the leading manufacturers in the areas of diagnosis, biopharmaceuticals, and molecular biology-grade reagents. High quality and low manufacturing cost is the key for success of marketing our products worldwide in a competitive price For another information you can contact us. |
---|---|
Industry Focus | Veterinary Medicine, Chemical Projects, Medical Testing & Laboratory Apparatus, Bio-technology Products |
Products/Services | Gnrh veterinary pharmaceutical, fertility buserelin blood, prostate cancer, animal raw material |
Our Markets | Worldwide |
No. of Employees | 11 - 50 People |
Year Established | 1992 |
Certificates | GOLD awarded for DNA Extraction kit from Malaysia BTA at 05 |